After years of debilitating bouts of fatigue, Beth VanOrden finally thought she had an answer to her problems in 2016 when ...

Palisade Bio, Inc, (Nasdaq: PALI) (“Palisade,” “Palisade Bio” or the “Company”), a clinical-stage biopharmaceutical company focused on developing novel therapeutics for autoimmune, inflammatory, and ...

Several rare immune disorders are caused by mutations in the patient's DNA. In a new study published in the Journal of ...

PGIM Jennison Health Sciences Fund recently released its third quarter 2024 investor letter. A copy of the letter can be ...

Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (the "Company" or "Coeptis"), a biopharmaceutical company focused on pioneering cell therapy platforms for cancer, autoimmune, and infectious ...

General Inception, a global biotech company igniter, and Enable Medicine, a leader in AI-led data analysis for biological research and drug discovery, today announce an equity and strategic ...

In Philadelphia’s Norris Square neighborhood, Shannon Turner, a celebrated singer, vocal coach, and founder of the band ...

Cells in the immune system don't always fight; they often rest and wait for threats, like viruses or bacteria.

Cells in the immune system don't always fight; they often rest and wait for threats, like viruses or bacteria. When such ...

Cyrus Biotechnology announces potent in vivo redosability of an engineered IdeS protease for IgG-driven autoimmune disease.

Autoimmune diseases arise when the immune system mistakenly targets and damages the body’s cells and tissues as though they were foreign invaders. This widespread category of illnesses, such as ...

By far, the largest acquisition of 2024 was Novo Holdings' yet-to-be-closed buyout of manufacturer Catalent at $16.5 billion.